TABLE 1.
Patient Demographic and Clinical Characteristics, and Final Outcomes Disaggregated by Pregnancy Status at ART Initiation
| LTFU | Pregnant Women | Nonpregnant Women | Men | |
| 1017 | 280 | 487 | 250 | |
| N (%) | N (%) | N (%) | N (%) | |
| Age | ||||
| 18–29 | 333 (32.7) | 150 (53.6) | 157 (32.2) | 26 (10.4) |
| 30–44 | 484 (47.6) | 124 (44.3) | 226 (46.4) | 134 (53.6) |
| 45–59 | 141 (13.9) | 6 (2.1) | 70 (14.4) | 65 (26.0) |
| 60+ | 58 (5.7) | 0 (0) | 33 (6.8) | 25 (10.0) |
| Missing | 1 (0.1) | 0 (0) | 1 (0.2) | 0 (0) |
| ART reason | ||||
| CD4 | 549 (54.0) | 0 (0) | 376 (77.2) | 173 (69.2) |
| PMTCT | 280 (27.5) | 280 (100.0) | 0 (0) | 0 (0) |
| WHO Stage | 77 (7.6) | 0 (0) | 45 (9.2) | 32 (12.8) |
| Test and treat | 43 (4.2) | 0 (0) | 23 (4.7) | 20 (8.0) |
| TB | 39 (3.8) | 0 (0) | 17 (3.5) | 22 (8.8) |
| Missing | 29 (2.9) | 0 (0) | 26 (5.3) | 3 (1.2) |
| ART start yr | ||||
| 2014 | 211 (20.8) | 58 (20.7) | 101 (20.7) | 52 (20.8) |
| 2015 | 414 (40.7) | 105 (37.5) | 212 (43.5) | 97 (38.8) |
| 2016 | 350 (34.4) | 107 (38.2) | 157 (32.2) | 86 (34.4) |
| 2017 | 42 (4.1) | 10 (3.6) | 17 (3.5) | 15 (6.0) |
| Time on ART | ||||
| ≤3 mo | 325 (32.0) | 89 (31.8) | 136 (27.9) | 100 (40.0) |
| 3–6 mo | 190 (18.7) | 70 (25.0) | 88 (18.1) | 32 (12.8) |
| 6–12 mo | 228 (22.4) | 70 (25.0) | 114 (23.4) | 44 (17.6) |
| 12–24 mo | 219 (21.5) | 39 (13.9) | 120 (24.6) | 60 (24.0) |
| >24 mo | 55 (5.4) | 12 (4.3) | 29 (6.0) | 14 (5.6) |
| Baseline CD4 | ||||
| <100 | 206 (20.2) | 14 (5.0) | 106 (21.8) | 86 (34.4) |
| 100–199 | 185 (18.2) | 38 (13.6) | 87 (17.9) | 60 (24.0) |
| 200–349 | 261 (25.7) | 71 (25.4) | 129 (26.5) | 61 (24.4) |
| 350–499 | 193 (19.0) | 74 (26.4) | 95 (19.5) | 24 (9.6) |
| 500+ | 145 (14.3) | 64 (22.9) | 64 (13.1) | 17 (6.8) |
| Missing | 27 (2.6) | 19 (6.8) | 6 (1.2) | 2 (0.8) |
| Baseline WHO stage | ||||
| I | 722 (71.9) | 261 (93.2) | 329 (67.6) | 132 (52.8) |
| II | 143 (14.1) | 17 (6.1) | 73 (15.0) | 53 (21.2) |
| III | 129 (12.7) | 2 (0.7) | 70 (14.4) | 57 (22.8) |
| IV | 10 (1.0) | 0 (0) | 6 (1.2) | 4 (1.6) |
| Missing | 13 (1.3) | 0 (0) | 9 (1.8) | 4 (1.6) |
| Refill schedule | ||||
| 1 mo | 672 (66.1) | 188 (67.1) | 322 (66.1) | 162 (64.8) |
| 2 mo | 233 (22.9) | 68 (24.3) | 102 (20.9) | 63 (25.2) |
| 3 mo | 79 (7.8) | 20 (7.1) | 44 (9.0) | 15 (6.0) |
| >3 mo | 33 (3.2) | 4 (1.4) | 19 (3.9) | 10 (4.0) |
| Health facility | ||||
| Agincourt | 272 (26.7) | 74 (26.4) | 141 (28.9) | 57 (22.8) |
| Belfast | 186 (18.3) | 64 (22.9) | 80 (16.4) | 42 (16.8) |
| Cunningmore | 58 (5.7) | 16 (5.7) | 32 (6.6) | 10 (4.0) |
| Justicia | 120 (11.8) | 42 (15.0) | 42 (8.6) | 36 (14.4) |
| Kildare | 117 (11.5) | 25 (8.9) | 62 (12.7) | 30 (12.0) |
| Lillydale | 166 (16.3) | 32 (11.4) | 81 (16.6) | 53 (21.2) |
| Thulamahashe | 25 (2.5) | 9 (3.2) | 12 (2.5) | 4 (1.6) |
| Xanthia | 73 (7.2) | 18 (6.4) | 32 (7.6) | 18 (7.2) |
| Time since last appointment | ||||
| ≤1 yr | 526 (51.7) | 130 (46.4) | 255 (52.4) | 141 (56.4) |
| 1–2 yrs | 369 (36.3) | 117 (41.8) | 176 (36.1) | 76 (30.4) |
| >2 yrs | 122 (12.0) | 33 (11.8) | 56 (11.5) | 33 (13.2) |
| AHDSS outcome | ||||
| Still in HDSS | 505 (49.7) | 142 (50.7) | 237 (48.7) | 126 (50.4) |
| Deceased | 74 (7.3) | 6 (2.1) | 42 (8.6) | 26 (10.4) |
| Migrated | 270 (26.5) | 99 (35.4) | 125 (25.7) | 46 (18.4) |
| Not linked | 168 (16.5) | 33 (11.8) | 83 (17.0) | 52 (20.8) |
| Final outcome | ||||
| Deceased | 120 (11.8) | 10 (3.6) | 60 (12.3) | 50 (20.0) |
| Transferred out | 315 (31.0) | 82 (29.3) | 176 (36.1) | 57 (22.8) |
| Stopped ART | 75 (7.4) | 28 (10.0) | 20 (4.1) | 27 (10.8) |
| Migrated | 49 (4.8) | 21 (7.5) | 22 (4.5) | 6 (2.4) |
| Reengaged | 225 (22.1) | 54 (19.3) | 110 (22.6) | 61 (24.4) |
| Alive: ART unknown | 111 (10.9) | 45 (16.1) | 45 (9.2) | 21 (8.4) |
| LTFU | 122 (12.0) | 40 (14.3) | 54 (11.1) | 28 (11.2) |